Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-09484-8.pdf
Reference47 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA: a cancer journal for clinicians 66, 7–30, doi: 10.3322/caac.21332 (2016).
2. Chen, W. et al. Cancer statistics in China, 2015. CA: a cancer journal for clinicians 66, 115–132, doi: 10.3322/caac.21338 (2016).
3. Qi, D. et al. Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009. The Prostate 75, 1662–1668, doi: 10.1002/pros.23046 (2015).
4. Park, J. C. & Eisenberger, M. A. Advances in the Treatment of Metastatic Prostate Cancer. Mayo Clin. Proc. 90, 1719–1733, doi: 10.1016/j.mayocp.2015.10.010 (2015).
5. Dai, B., Ye, D.-W., Kong, Y.-Y., Shen, Y.-J. & Wang, B.-H. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels. Asian Journal of Andrology 10, 325–331, doi: 10.1111/j.1745-7262.2008.00345.x (2008).
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pembrolizumab for metastatic castration-resistant prostate cancer: trials and tribulations;Expert Opinion on Biological Therapy;2024-01-29
2. TIM-3 regulates the proliferation by BDNF-mediated PI3K/AKT axis in the process of endometriosis;Molecular Medicine;2023-12-19
3. IL8 derived from macrophages inhibits CD8+ T-cell function by downregulating TIM3 expression through IL8-CXCR2 axis in patients with advanced colorectal cancer;International Immunopharmacology;2023-08
4. Tumor immunology;Clinical Immunology;2023
5. Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy;Frontiers in Genetics;2022-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3